Design News is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Electroactive Polymers Target Medical Device Applications

Electroactive Polymers Target Medical Device Applications

An Irish company is actively investigating potential applications in medical devices for a novel conductive polymer that changes volume and other properties in response to an electrical stimulus.

Potential applications include:

  • minimally invasive devices with enhanced maneuverability, such as guidewires, catheters and leads,
  • delivery and retrieval devices, such as embolic coils used for implant detachment,
  • microsurgical tools for ophthalmic surgery, neurosurgery or fetal surgery, and
  • conducting polymer coatings for neurostimulation.

"In terms of commercial applications of Micromuscle, there are currently no FDA-approved devices incorporating the technology, but there are a number of applications currently being researched," says Maura Leahy, marketing manager for Creganna, a medical device development company based in Galway, Ireland.

The underlying technology is based on electroactive polymers developed by the University of Linköping in Sweden. The polymers swell and contract as ions and water enter the polymer when a small voltage (typically 1-2V) is applied. When the voltage is removed or reversed, the polymer contracts and resumes its original shape.

The bulk volume change of the polymer forms a swelling "volumetric" actuator, in one of the potential uses. In some instances, the polymer may be attached to a metal. An electric current would cause the entire structure to bend.

Creganna recently acquired the patents for the technology from Micromuscle AB of Sweden after the withdrawal of a venture capitalist forced the Swedish company to seek voluntary liquidation.

Micromuscle was founded in 2000 as a spin-off from leading research on conducting polymers at Linköping University. The main shareholders of Micromuscle were Industrifonden, CIMON Medical and Iteksa Venture.

One of the key patents for the technology, "Micro tools", was granted by the U.S. Patent Office on Feb. 19, 2008. The electroactive polymers used by Micromuscle are from the group consisting of pyrrole, aniline, thiophene, para-phenylene, vinylene and phenylene polymer. The discovery of electrically conductive polymers was awarded the Nobel Prize in 2000. Micromuscle is described as the most advanced application of the technology for the medical device arena, particularly for minimally invasive therapies.

 Electroactive Polymers Target Medical Device Applications

TAGS: Medical
Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish